CDSCO issued an alert on theft of Lantus® SoloStar® (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL Batch No. 5F0347B of M/s Sanofi India Limited during transit

Mar 04, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Central Drugs Standard Control Organization (CDSCO), on March 02, 2026, issued an alert on theft of Lantus® SoloStar® (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL Batch No. 5F0347B of M/s Sanofi India Limited during transit.

The following has been stated namely: -

The following advisory is provided:

• Doctors and Healthcare professionals:- Carefully prescribe and educate the patients for reporting of any ADRs.

• Patients and consumers:- To be careful and procure the above products from authorized sources only and with proper invoice.

• Regulatory authorities (All state/UT Drugs Controllers and Zonal/Sub-Zonal offices of CDSCO):- Instruct your officers to keep a strict vigil on the movement of the said products in the market and initiate necessary action under the provisions of Drugs & Cosmetics Act, 1940 and Rules made thereunder

[Notification no. F. No. Enforc-11021(11)/18/2026-eoffice]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT